SciClone slides after premarket head fake


SciClone Pharmaceuticals (SCLN -4.8%) falls after teasing a sharp gain in premarket trading.

Full year EPS guidance of $0.55-0.61 is below consensus of $0.63.

CC transcript

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs